losartan has been researched along with Carcinoma, Ductal, Pancreatic in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "On murine models of pancreatic cancer, Los NB shows a greater ability to remodel the tumor microenvironment than free losartan, including stromal depletion, vessel perfusion increase, and hypoxia relief." | 1.72 | Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer. ( Bian, S; Chen, J; Dong, H; Jia, X; Li, Z; Qiu, N; Song, P; Song, W; Wang, H; Zhao, L; Zheng, S; Zhu, X, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, S | 1 |
| Dong, H | 1 |
| Zhao, L | 1 |
| Li, Z | 2 |
| Chen, J | 1 |
| Zhu, X | 1 |
| Qiu, N | 1 |
| Jia, X | 1 |
| Song, W | 1 |
| Zheng, S | 1 |
| Wang, H | 1 |
| Song, P | 1 |
| Gong, Q | 2 |
| Davis, M | 1 |
| Chipitsyna, G | 2 |
| Yeo, CJ | 2 |
| Arafat, HA | 2 |
| Pérez-Díaz, I | 1 |
| Guzmán, C | 1 |
| Olivares-Reyes, JA | 1 |
| Ramírez, T | 1 |
| Gutierréz-Reyes, G | 1 |
| Hiriart, M | 1 |
| Robles-Díaz, G | 1 |
| Anandanadesan, R | 1 |
| Witkiewicz, A | 1 |
4 other studies available for losartan and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Fatty Acids; Irinote | 2022 |
Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Pancreati | 2010 |
Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Binding Sites; Carcinoma, Pa | 2011 |
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Carcinoma, Pancreatic Du | 2008 |